Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001815776-26-000013
Filing Date
2026-03-24
Accepted
2026-03-24 16:27:33
Documents
14
Effectiveness Date
2026-03-24

Document Format Files

Seq Description Document Type Size
1 S-8 lenz-sx82026.htm S-8 63100
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 25863
3 EX-5.1 exhibit51-sx82026.htm EX-5.1 9512
4 EX-23.1 exhibit231-sx82026.htm EX-23.1 2026
5 wilsonsonsinilogo.jpg GRAPHIC 375685
  Complete submission text file 0001815776-26-000013.txt   741411

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 10055
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-294569 | Film No.: 26786674
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)